This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2003 Jul 5;362(9377):80; author reply 80.

doi: 10.1016/S0140-6736(03)13823-8.

Mutations in BRCA1 and BRCA2 and predisposition to prostate cancer

Marc Tischkowitz, Ros Eeles; IMPACT study: Identification of Men with genetic predisposition to Prostate Cancer and its Clinical Treatment collaborators

PMID: 12853213
DOI: 10.1016/S0140-6736(03)13823-8

Comment

Mutations in BRCA1 and BRCA2 and predisposition to prostate cancer

Marc Tischkowitz et al. Lancet. 2003.

. 2003 Jul 5;362(9377):80; author reply 80.

doi: 10.1016/S0140-6736(03)13823-8.

Authors

Marc Tischkowitz, Ros Eeles; IMPACT study: Identification of Men with genetic predisposition to Prostate Cancer and its Clinical Treatment collaborators

PMID: 12853213
DOI: 10.1016/S0140-6736(03)13823-8

No abstract available

PubMed Disclaimer

Comment on

Prostate cancer epidemiology.
Grönberg H. Grönberg H. Lancet. 2003 Mar 8;361(9360):859-64. doi: 10.1016/S0140-6736(03)12713-4. Lancet. 2003. PMID: 12642065 Review.

Similar articles

Male BRCA1 and BRCA2 mutation carriers: a pilot study investigating medical characteristics of patients participating in a prostate cancer prevention clinic.
Horsburgh S, Matthew A, Bristow R, Trachtenberg J. Horsburgh S, et al. Prostate. 2005 Oct 1;65(2):124-9. doi: 10.1002/pros.20278. Prostate. 2005. PMID: 15880530
BRCA1 and BRCA2 mutations have no major role in predisposition to prostate cancer in Finland.
Ikonen T, Matikainen MP, Syrjäkoski K, Mononen N, Koivisto PA, Rökman A, Seppälä EH, Kallioniemi OP, Tammela TL, Schleutker J. Ikonen T, et al. J Med Genet. 2003 Aug;40(8):e98. doi: 10.1136/jmg.40.8.e98. J Med Genet. 2003. PMID: 12920090 Free PMC article. No abstract available.
The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel.
Vazina A, Baniel J, Yaacobi Y, Shtriker A, Engelstein D, Leibovitz I, Zehavi M, Sidi AA, Ramon Y, Tischler T, Livne PM, Friedman E. Vazina A, et al. Br J Cancer. 2000 Aug;83(4):463-6. doi: 10.1054/bjoc.2000.1249. Br J Cancer. 2000. PMID: 10945492 Free PMC article.
[Update on genetic predisposition to prostate cancer].
Cussenot O, Cancel-Tassin G. Cussenot O, et al. Bull Cancer. 2015 Jan;102(1):53-6. doi: 10.1016/j.bulcan.2014.12.007. Epub 2014 Dec 29. Bull Cancer. 2015. PMID: 25609482 Review. French.
Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature.
Liede A, Karlan BY, Narod SA. Liede A, et al. J Clin Oncol. 2004 Feb 15;22(4):735-42. doi: 10.1200/JCO.2004.05.055. J Clin Oncol. 2004. PMID: 14966099 Review.

See all similar articles

Cited by

The Role of Next-Generation Sequencing in Castration-Resistant Prostate Cancer Treatment.
Hovelson DH, Tomlins SA. Hovelson DH, et al. Cancer J. 2016 Sep/Oct;22(5):357-361. doi: 10.1097/PPO.0000000000000217. Cancer J. 2016. PMID: 27749331 Free PMC article. Review.
Cancer biomarker discovery: the entropic hallmark.
Berretta R, Moscato P. Berretta R, et al. PLoS One. 2010 Aug 18;5(8):e12262. doi: 10.1371/journal.pone.0012262. PLoS One. 2010. PMID: 20805891 Free PMC article.
The clinical genetics of prostate cancer.
Kommu S, Edwards S, Eeles R. Kommu S, et al. Hered Cancer Clin Pract. 2004 Jul 15;2(3):111-21. doi: 10.1186/1897-4287-2-3-111. Hered Cancer Clin Pract. 2004. PMID: 20233465 Free PMC article.
Translational and clinical implications of the genetic landscape of prostate cancer.
Spratt DE, Zumsteg ZS, Feng FY, Tomlins SA. Spratt DE, et al. Nat Rev Clin Oncol. 2016 Oct;13(10):597-610. doi: 10.1038/nrclinonc.2016.76. Epub 2016 Jun 1. Nat Rev Clin Oncol. 2016. PMID: 27245282 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal